Weekly Newsletter

Dafinchi Weekly Newsletter

The earnings shifts, investor discussions, and market signals worth knowing—summarized in one concise email.

Email address

Delivered every week. Unsubscribe anytime.

Latest Earnings

Highlights Feed Latest Earnings Newsletter Blog Company Finder

Newsletternew My Portfolio Highlights Feed Latest Earnings Annual Reviews Earnings Chat Earnings Coach Keyword Scan Deep Research Company Finder Blog Guides Compare Earnings Shareholder Letter History

Quick Links

MCP — Connect your AI About Us FAQs Contact Us Privacy Policy Cookies Policy Terms and Condition Acceptable Use Policy Data Processing Addendum

Contents

Aktis Oncology, Inc. (AKTS) Q2 2022 Earnings Transcript - Dafinchi AI

AKTS Q2 2022

Release Date: Jan 31, 2022

AKTS (Aktis Oncology, Inc.)

Aktis Oncology, Inc. is a clinical-stage biotechnology firm dedicated to advancing targeted radiopharmaceutical therapies for cancer treatment. Their core innovation lies in a proprietary miniprotein ...view more

IndustryBiotechnology

SectorHealthcare

HQBoston, MA

Employees79

Sign in to unlock the full earnings breakdown

Get key highlights, executive quotes, the full transcript, and clear answers to your questions in one place.

What you'll get after signing in:

Stock price performance

Key financial metrics

Top discussion topics

Executive highlights

Full earnings transcript

Ask and get clear answers